AMRN vs PFE · rev $87.3M vs P/E 20, rev $15.03B
Amarin Corporation PLC (AMRN) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Amarin Corporation PLC (AMRN) is a drug manufacturers - general company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AMRN revenue for 2026-06-30 was $87.3M. Net income was -$18.2M. Revenue was up 93.5% from 2026-03-31 to 2026-06-30. AMRN currently screens at market cap $292.1M.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AMRN currently screens at market cap $292.1M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AMRN and PFE stock pages for the full models.
Not investment advice.